These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15486247)

  • 1. Frequently asked questions: iodinated contrast agents.
    Bettmann MA
    Radiographics; 2004 Oct; 24 Suppl 1():S3-10. PubMed ID: 15486247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contrast-induced nephropathy].
    Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
    Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy.
    Elicker BM; Cypel YS; Weinreb JC
    AJR Am J Roentgenol; 2006 Jun; 186(6):1651-8. PubMed ID: 16714655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?
    Choyke PL; Cady J; DePollar SL; Austin H
    Tech Urol; 1998 Jun; 4(2):65-9. PubMed ID: 9623618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media].
    Kuefner MA; Heinrich M; Bautz W; Uder M
    Rontgenpraxis; 2008; 56(6):199-206. PubMed ID: 19294866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the risk of contrast-induced nephropathy: a perspective on the controversies.
    Ellis JH; Cohan RH
    AJR Am J Roentgenol; 2009 Jun; 192(6):1544-9. PubMed ID: 19457817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
    Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are referring clinicians aware of patients at risk from intravenous injection of iodinated contrast media?
    Konen E; Konen O; Katz M; Levy Y; Rozenman J; Hertz M
    Clin Radiol; 2002 Feb; 57(2):132-5. PubMed ID: 11977947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to intravenous iodinated contrast media: an update.
    Namasivayam S; Kalra MK; Torres WE; Small WC
    Curr Probl Diagn Radiol; 2006; 35(4):164-9. PubMed ID: 16814003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephropathy--prevention and risk reduction.
    Lameire NH
    Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal failure and iodinated contrast media. A review.
    Violon D
    JBR-BTR; 1999 Apr; 82(2):57-62. PubMed ID: 10874391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications related to the administration of iodinated contrast media].
    Cappeliez O; Lemort M; Dagnelie J
    Rev Med Brux; 1997 Dec; 18(6):373-8. PubMed ID: 9481156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contrast nephropathy and its prevention].
    Skulec R; Bĕlohlávek J; Kovárník T; Linhart A; Aschermann M
    Vnitr Lek; 2003 Feb; 49(2):127-33. PubMed ID: 12728580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iodinated contrast agents: risks and problematic situations.
    Bui KL; Horner JD; Herts BR; Einstein DM
    Cleve Clin J Med; 2007 May; 74(5):361-4, 367. PubMed ID: 17506241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
    Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM
    Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guideline 'Precautionary measures for contrast media containing iodine'].
    van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of contrast-induced nephropathy: an overview.
    Ellis JH; Cohan RH
    Radiol Clin North Am; 2009 Sep; 47(5):801-11, v. PubMed ID: 19744595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast safety in the cancer patient: preventing contrast-induced nephropathy.
    Heiken JP
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S124-7. PubMed ID: 18852085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children.
    Dillman JR; Strouse PJ; Ellis JH; Cohan RH; Jan SC
    AJR Am J Roentgenol; 2007 Jun; 188(6):1643-7. PubMed ID: 17515388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media.
    Thomsen HS
    Eur J Radiol; 2006 Dec; 60(3):307-13. PubMed ID: 16965884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.